Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Leukaemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01520519
What this trial is testing

Phase 2 Study of the Combination of Bruton's Tyrosine Kinase Inhibitor PCI-32765 and Rituximab in High-Risk Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)UnknownNCT00451711
What this trial is testing

Intermittent Liposomal Amphotericin B Primary Prophylaxis

Who this might be right for
Acute Myeloid Leukemia
Bayside Health 60
Early research (Phase 1)Ended earlyNCT02267863
What this trial is testing

APTO-253 in Patients With Relapsed or Refractory AML or MDS

Who this might be right for
Acute Myelogenous Leukemia in RelapseAcute Myelogenous Leukemia, Relapsed, AdultAcute Myelogenous Leukemia, Adult+2 more
Aptose Biosciences Inc. 21
Testing effectiveness (Phase 2)Study completedNCT00008190
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia

Who this might be right for
Leukemia
Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01995578
What this trial is testing

Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse

Who this might be right for
Myelodysplastic Syndromes (MDS)Acute Myelogenous Leukemia (AML)
Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Looking for participantsNCT05601726
What this trial is testing

First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients

Who this might be right for
Acute Myeloid Leukemia, AdultMyelodysplastic Syndromes
Advanced BioDesign 36
Early research (Phase 1)WithdrawnNCT02786485
What this trial is testing

Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT

Who this might be right for
LeukemiaMyelodysplastic SyndromesLymphomas+2 more
Bellicum Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00857389
What this trial is testing

Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies

Who this might be right for
Stem Cell TransplantationLeukemiaLymphoma
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT03792633
What this trial is testing

Study of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALL

Who this might be right for
Acute Lymphoblastic Leukemia
University of Pennsylvania 106
Testing effectiveness (Phase 2)Ended earlyNCT02599649
What this trial is testing

Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 10
Early research (Phase 1)Study completedNCT00002818
What this trial is testing

High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+1 more
Virginia Commonwealth University 15
Testing effectiveness (Phase 2)UnknownNCT01513109
What this trial is testing

Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia

Who this might be right for
Acute Myelogenous LeukemiaMyeloid Leukemia in RemissionEffects of Immunotherapy
Jules Bordet Institute 20
Early research (Phase 1)Looking for participantsNCT07573111
What this trial is testing

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute LeukemiaMyelodysplastic Syndrome
Laguna Biotherapeutics, Inc. 12
Early research (Phase 1)Study completedNCT03263637
What this trial is testing

Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies

Who this might be right for
Relapsed or Refractory Haematological Malignancies IncludingAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+8 more
AstraZeneca 44
Testing effectiveness (Phase 2)Study completedNCT00553202
What this trial is testing

Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 158
Testing effectiveness (Phase 2)Ended earlyNCT04526288
What this trial is testing

CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts-2Myeloid Neoplasm
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00004905
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia

Who this might be right for
Leukemia
Loyola University
Early research (Phase 1)Ended earlyNCT04196010
What this trial is testing

Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms

Who this might be right for
Myeloid NeoplasmRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
University of Washington 13
Early research (Phase 1)Study completedNCT02942290
What this trial is testing

A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes (MDS)
AbbVie 134
Testing effectiveness (Phase 2)Study completedNCT00188136
What this trial is testing

Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
University Hospital Carl Gustav Carus 32
Next Page